RYZB Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
RayzeBio Share Price & Price History
Current Price: $62.49
Price Change: +0.30 (1.20%)
As of 02/26/2024 01:00 AM ET
RayzeBio Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/19/2023 | Global Investors Lp Viking | Major Shareholder | Buy | 1,388,889 | $18.00 | $25,000,002.00 | 4,899,144 |  |
| 9/19/2023 | Maha Katabi | Director | Buy | 472,222 | $18.00 | $8,499,996.00 | 1,209,764 | |
RayzeBio Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 3/5/2024 | Wellington Management Group LLP | 3,504,409 | $215.91M | 0.0% | -9.6% | 5.848% |  |
| 2/26/2024 | Perceptive Advisors LLC | 744,056 | $46.26M | 1.0% | -4.2% | 1.242% | |
| 2/15/2024 | Blackstone Inc. | 108,090 | $6.72M | 0.0% | +8.1% | 0.180% | |
| 2/14/2024 | Hhlr Advisors LTD. | 1,062,383 | $66.05M | 1.3% | -23.9% | 1.773% | |
| 2/14/2024 | Commodore Capital LP | 383,638 | $23.85M | 2.1% | +32.8% | 0.640% | |
| 2/14/2024 | PenderFund Capital Management Ltd. | 1,800 | $0.11M | 0.0% | N/A | 0.003% | |
| 2/14/2024 | Harvest Management LLC | 50,000 | $3.11M | 2.9% | N/A | 0.083% | |
| 2/14/2024 | Water Island Capital LLC | 225,565 | $14.02M | 1.4% | N/A | 0.376% | |
| 2/13/2024 | GABELLI & Co INVESTMENT ADVISERS INC. | 38,850 | $2.42M | 0.5% | N/A | 0.065% | |
| 2/13/2024 | Gabelli Funds LLC | 52,600 | $3.27M | 0.0% | N/A | 0.088% | |
| 2/13/2024 | Tower Research Capital LLC TRC | 826 | $51K | 0.0% | +403.7% | 0.001% | |
| 2/13/2024 | Capital Research Global Investors | 170,808 | $10.62M | 0.0% | -86.3% | 0.285% | |
| 2/9/2024 | Franklin Resources Inc. | 511,401 | $31.79M | 0.0% | -38.6% | 0.853% | |
| 2/7/2024 | Versor Investments LP | 80,771 | $5.02M | 1.0% | N/A | 0.135% | |
| 2/7/2024 | Alpine Associates Management Inc. | 762,900 | $47.43M | 2.4% | N/A | 1.273% | |
| 2/7/2024 | Kellner Capital LLC | 12,200 | $0.76M | 1.4% | N/A | 0.020% | |
| 2/7/2024 | Vivo Capital LLC | 110,581 | $6.88M | 0.6% | -82.5% | 0.185% | |
| 2/6/2024 | Charles Schwab Investment Management Inc. | 147,140 | $9.15M | 0.0% | N/A | 0.246% | |
| 2/6/2024 | BCK Capital Management LP | 15,000 | $0.93M | 0.9% | N/A | 0.025% | |
| 2/6/2024 | M&T Bank Corp | 7,480 | $0.47M | 0.0% | N/A | 0.012% | |
| 2/6/2024 | Amalgamated Bank | 2,347 | $0.15M | 0.0% | N/A | 0.004% | |
| 2/5/2024 | Victory Capital Management Inc. | 4,055 | $0.25M | 0.0% | N/A | 0.007% | |
| 2/1/2024 | Wolverine Asset Management LLC | 11,700 | $0.73M | 0.0% | N/A | 0.020% | |
| 2/1/2024 | New York State Common Retirement Fund | 8,969 | $0.56M | 0.0% | +796.9% | 0.015% | |
| 1/30/2024 | Strs Ohio | 4,300 | $0.27M | 0.0% | N/A | 0.007% | |
| 1/12/2024 | SG Americas Securities LLC | 8,138 | $0.51M | 0.0% | N/A | 0.014% | |
| 12/13/2023 | Teachers Retirement System of The State of Kentucky | 19,131 | $0.43M | 0.0% | N/A | 0.032% | |
| 12/6/2023 | Citigroup Inc. | 24,907 | $0.55M | 0.0% | N/A | 0.042% | |
| 12/1/2023 | Wellington Management Group LLP | 3,876,186 | $84.49M | 0.0% | N/A | 6.469% | |
| 11/15/2023 | RTW Investments LP | 46,300 | $1.03M | 0.0% | N/A | 0.080% | |
| 11/15/2023 | Redmile Group LLC | 1,857,706 | $41.24M | 2.0% | N/A | 3.192% | |
| 11/15/2023 | Laurion Capital Management LP | 971,913 | $21.58M | 0.1% | N/A | 1.670% | |
| 11/15/2023 | Acuta Capital Partners LLC | 344,571 | $7.65M | 5.1% | N/A | 0.592% | |
| 11/14/2023 | venBio Partners LLC | 5,158,162 | $114.51M | 32.5% | N/A | 8.864% | |
| 11/14/2023 | Braidwell LP | 277,778 | $6.17M | 0.2% | N/A | 0.477% | |
| 11/14/2023 | Blackstone Inc. | 100,000 | $2.22M | 0.0% | N/A | 0.172% | |
| 11/14/2023 | Soros Fund Management LLC | 20,000 | $0.44M | 0.0% | N/A | 0.034% | |
| 11/14/2023 | Deerfield Management Company L.P. Series C | 1,159,126 | $25.73M | 0.6% | N/A | 1.992% | |
| 11/14/2023 | Avidity Partners Management LP | 500,000 | $11.10M | 0.4% | N/A | 0.859% | |
| 11/14/2023 | Monashee Investment Management LLC | 27,500 | $0.61M | 0.3% | N/A | 0.047% | |
| 11/13/2023 | FMR LLC | 1,138,972 | $25.29M | 0.0% | N/A | 1.957% | |
| 11/13/2023 | Maven Securities LTD | 59,835 | $1.33M | 0.0% | N/A | 0.103% | |
| 11/9/2023 | Citigroup Inc. | 24,907 | $0.55M | 0.0% | N/A | 0.043% | |
| 11/8/2023 | Vivo Capital LLC | 633,576 | $14.07M | 1.7% | N/A | 1.089% | |
| 11/3/2023 | Versant Venture Management LLC | 5,158,161 | $114.51M | 61.0% | N/A | 8.864% | |
| 11/3/2023 | Platinum Investment Management Ltd. | 222,222 | $4.93M | 0.2% | N/A | 0.382% | |
| 10/27/2023 | TD Asset Management Inc | 72,610 | $1.61M | 0.0% | N/A | 0.125% | |
Data available starting January 2016
RayzeBio, Inc. develops radiopharmaceutical therapeutics (RPT) for the treatment of cancer. The company's lead drug candidate is RYZ101, which is in phase 3 clinical trial for the treatment of gasteroenteropancreatic neuroendocrine tumors (GEP-NETs). It also develops RYZ801, a novel proprietary peptide that targets GPC3 for delivery of Ac225 for the treatment of hepatocellular carcinoma (HCC); RYZ811, a paired diagnostic imaging agent with the peptide binder, chelator, and Ga68 as the radioisotope; and a novel proprietary small molecule that targets CA9 for delivery of Ac225 for the treatment of ccRCC. The company was incorporated in 2020 and is based in San Diego, California. As of February 26, 2024, RayzeBio, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Read More on RayzeBio
Today's Range
Now: $62.49
52 Week Range
Now: $62.49
Volume
N/A
Average Volume
553,592 shs
Market Capitalization
$3.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
